Latest filing published 11 Dec 2019 for Eidos Therapeutics, Inc., €5,335.
Filing timeline
BuySaleInsider track record
Christine Siu: trading record in brief
Christine Siu discloses dealings in Eidos Therapeutics, Inc. to SEC (Form 4). The record holds 29 filings, for trades running from 30 November 2018 to 9 December 2019.
No open-market purchase appears, only 17 sales worth €4.3M. Outside the open market, there are 2 share grants and 10 option exercises. Since January 2019: no purchases and 17 sales on the market.
Most recently, on 11 December 2019, the filings show an option exercise worth €5,335 in Eidos Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christine Siu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$0.590.1% of flowCommon StockSEC:0000899243-19-028932:0
- 9,099 shares@ US$59.618511.2% of flowCommon StockSEC:0000899243-19-028932:1
- 901 shares@ US$60.04561.1% of flowCommon StockSEC:0000899243-19-028932:2
- 10,000 shares@ US$0.590.1% of flowCommon StockSEC:0000899243-19-028602:0
- 600 shares@ US$57.82120.7% of flowCommon StockSEC:0000899243-19-028602:1
- 5,400 shares@ US$58.95046.5% of flowCommon StockSEC:0000899243-19-028602:2
- 4,000 shares@ US$59.64574.9% of flowCommon StockSEC:0000899243-19-028602:3
- 10,000 shares@ US$0.590.1% of flowCommon StockSEC:0000899243-19-028602:4
- 8,800 shares@ US$58.59910.6% of flowCommon StockSEC:0000899243-19-028602:5
- 1,200 shares@ US$59.39321.5% of flowCommon StockSEC:0000899243-19-028602:6
- 200 shares@ US$56.000.2% of flowCommon StockSEC:0000899243-19-028027:2
- 25,000 shares@ US$0.590.3% of flowCommon StockSEC:0000899243-19-028027:0
- 24,800 shares@ US$55.11628.1% of flowCommon StockSEC:0000899243-19-028027:1
- 10,000 shares@ US$0.590.1% of flowCommon StockSEC:0000899243-19-028027:3
- 9,399 shares@ US$54.710510.6% of flowCommon StockSEC:0000899243-19-028027:4
- 601 shares@ US$55.29490.7% of flowCommon StockSEC:0000899243-19-028027:5
- 5,000 shares@ US$0.590.1% of flowCommon StockSEC:0000899243-19-019526:0
- 5,000 shares@ US$39.374.0% of flowCommon StockSEC:0000899243-19-019526:1
- 17,000 shares@ US$0.590.2% of flowCommon StockSEC:0000899243-19-018521:0
- 300 shares@ US$31.030.2% of flowCommon StockSEC:0000899243-19-016042:3
- 1,769 shares@ US$12.010.4% of flowCommon StockSEC:0000899243-19-016042:0
- 3,279 shares@ US$29.342.0% of flowCommon StockSEC:0000899243-19-016042:1
- 13,421 shares@ US$30.108.2% of flowCommon StockSEC:0000899243-19-016042:2
- 5,000 shares@ US$0.590.1% of flowCommon StockSEC:0000899243-19-011239:0
- 5,000 shares@ US$26.112.7% of flowCommon StockSEC:0000899243-19-011239:1
25 of 29 declarations
